Related Experiment Video
Updated: Mar 22, 2026
07:32
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
8.4K
Cytotoxic Tumor-Targeting Peptides From In Vivo Phage Display
Jessica R Newton Northup, Susan L Deutscher1
1Department of Biochemistry, University of Missouri, and Harry S. Truman Veterans Memorial Hospital, 117 Schweitzer Hall, Columbia, MO 65211, USA. deutschers@missouri.edu.
Combinatorial Chemistry & High Throughput Screening
|April 9, 2016
Summary
New phage display technology identifies prostate cancer cell-killing molecules. These novel agents target and reduce prostate cancer cell attachment and proliferation, offering a potential new therapeutic approach.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Phage display is a powerful technique for identifying molecules with specific binding properties.
- In vivo selection methods allow for the isolation of molecules that target specific tissues within a living organism.
- Prostate cancer remains a significant health concern, necessitating the development of novel therapeutic strategies.
Purpose of the Study:
- To investigate the potential of in vivo phage display selection to identify not only tumor-targeting but also tumor-killing molecules.
- To analyze two specific phage clones (G1 and H5) derived from in vivo selection against prostate cancer xenografts for their cytotoxic effects.
Main Methods:
- In vivo peptide phage display selection was used to isolate tumor-targeting phage.
- PC-3 human prostate carcinoma cells were incubated with selected phage clones (G1 and H5).
- Cell attachment, cell cycle progression (M phase), caspase activation, and tubulin interactions were analyzed to assess cytotoxicity.
Main Results:
- Both G1 and H5 phage clones significantly reduced PC-3 cell attachment and the percentage of cells in M phase.
- Elevated caspase activation was observed in M phase cells, suggesting apoptosis induction in actively dividing cells.
- G1 phage induced and co-localized with tubulin projections in apoptotic cells, indicating a specific mechanism of action.
Conclusions:
- The in vivo phage display selection technique can identify molecules with dual targeting and cytotoxic capabilities against prostate cancer cells.
- Phage clones G1 and H5 demonstrate significant anti-prostate cancer activity by inducing apoptosis and cell cycle arrest.
- These cytotoxic phages represent promising candidates for the development of novel targeted prostate cancer therapeutics.
